Octreotide Acetate Injection, Solution
Product Images NDC 0641-6178

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 0641-6178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Octreotide Acetate Injection 1)

FDA Label Image

West-ward Logo (Octreotide Acetate Injection 2)

West-ward Logo (Octreotide Acetate Injection 2)
This is a description for a pharmaceutical product called "Octreotide Acetate Injection". It is provided in a 1 mL single-dose vial with a concentration of 50 mg/mL and is used for subcutaneous injection. The recommended storage temperature is between 2°C and 8°C. The manufacturer of this product is Hikma.*
FDA Label Image

50 Mcg/ml Container Label (Octreotide Acetate Injection 3)

50 Mcg/ml Container Label (Octreotide Acetate Injection 3)
This is a product description for Octreotide Acetate Injection with a concentration of 100mcg/mL. It is intended for subcutaneous injection and is stored at a temperature range of 2 to 8°C. The medication is provided in a 1mL single-dose vial manufactured by Hikma. The rest of the text is not-readable and may contain errors.*
FDA Label Image

462-720-01 (Octreotide Acetate Injection 4)

462-720-01 (Octreotide Acetate Injection 4)
This is a product description of Octreotide Acetate Injection by Hikma. The recommended method of administration is subcutaneous injection and it is advised to be stored at a temperature range of 2°C to 8°C. The product information also indicates that it is available in a 1mL single-dose vial. However, some characters from the text are not readable since they are unrecognizable.*
FDA Label Image

100 Mcg/ml Container Label (Octreotide Acetate Injection 5)

100 Mcg/ml Container Label (Octreotide Acetate Injection 5)
Octreotide Acetate Injection is a type of medication that comes in a 5 mL multiple-dose vial with a concentration of 200 meg/mL. The injection is intended for subcutaneous use. The dosage information can be found in the package insert. It is recommended to store the vial in a refrigerator between 2-8°C (36-46°F) and protect it from light. After opening, it should be discarded within 14 days. The manufacturer of the medication is Hira.*
FDA Label Image

462-722-01 (Octreotide Acetate Injection 6)

462-722-01 (Octreotide Acetate Injection 6)
NDC 0641617801 Ronly OCTREOTIDE Acetate Injection with a concentration of 1,000 mg/mL is designed for subcutaneous injections. The instructions state that it should be kept in a refrigerator at 2 to 8°C (36° to 46°F) to protect it from light. It is important to use within 14 days after opening the vaccine. The manufacturer of the vaccine is Hima Sty Hagn., 10722. The package insert should be referred to for the normal dosage.*
FDA Label Image

500 Mcg/mlcontainer Label (Octreotide Acetate Injection 7)

500 Mcg/mlcontainer Label (Octreotide Acetate Injection 7)
This is a product identification code that includes a Global Trade Item Number (GTIN) and a Serial Number (SN). Additionally, there is an expiration date indicated by a code of month and year (EXP MMMYYYY), and a lot number (LOT ABCDE12345).*
FDA Label Image

462-724-01 (Octreotide Acetate Injection 8)

462-724-01 (Octreotide Acetate Injection 8)
This is a product or item identification document containing a lot (or batch) number of ABCDET2345, an expiration date of HHRYYYY, a GTIN (Global Trade Item Number) of 0301234567896, and a serial number of 12345678901234.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.